Cargando…

Considering comorbidity in managing rheumatic diseases: going where trials cannot go

Detalles Bibliográficos
Autores principales: Aletaha, Daniel, Dörner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218897/
https://www.ncbi.nlm.nih.gov/pubmed/21722343
http://dx.doi.org/10.1186/ar3354
_version_ 1782216752593108992
author Aletaha, Daniel
Dörner, Thomas
author_facet Aletaha, Daniel
Dörner, Thomas
author_sort Aletaha, Daniel
collection PubMed
description
format Online
Article
Text
id pubmed-3218897
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32188972011-12-29 Considering comorbidity in managing rheumatic diseases: going where trials cannot go Aletaha, Daniel Dörner, Thomas Arthritis Res Ther Editorial BioMed Central 2011 2011-06-29 /pmc/articles/PMC3218897/ /pubmed/21722343 http://dx.doi.org/10.1186/ar3354 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Editorial
Aletaha, Daniel
Dörner, Thomas
Considering comorbidity in managing rheumatic diseases: going where trials cannot go
title Considering comorbidity in managing rheumatic diseases: going where trials cannot go
title_full Considering comorbidity in managing rheumatic diseases: going where trials cannot go
title_fullStr Considering comorbidity in managing rheumatic diseases: going where trials cannot go
title_full_unstemmed Considering comorbidity in managing rheumatic diseases: going where trials cannot go
title_short Considering comorbidity in managing rheumatic diseases: going where trials cannot go
title_sort considering comorbidity in managing rheumatic diseases: going where trials cannot go
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218897/
https://www.ncbi.nlm.nih.gov/pubmed/21722343
http://dx.doi.org/10.1186/ar3354
work_keys_str_mv AT aletahadaniel consideringcomorbidityinmanagingrheumaticdiseasesgoingwheretrialscannotgo
AT dornerthomas consideringcomorbidityinmanagingrheumaticdiseasesgoingwheretrialscannotgo